Literature DB >> 2907416

Morphine can stimulate prolactin release independent of a dopaminergic mechanism.

S H Shin1, M C Obonsawin, D A Van Vugt, N Baby, K Jhamandas.   

Abstract

Prolactin release is controlled by prolactin-release inhibiting factor (PIF), possibly dopamine, and an unidentified putative hypothalamic prolactin-releasing factor (PRF). Morphine and related opioids may indirectly stimulate prolactin release by inhibiting PIF release and (or) by stimulating putative PRF release. In the present study, we have completely blocked the dopaminergic receptors in normal male rats by pretreatment with a large dose of pimozide (3 mg/kg) to demonstrate if putative PRF has a role in morphine-induced prolactin release. Morphine sulfate (10 mg/kg) was still able to stimulate prolactin release in the rat without any functional dopaminergic PIF receptors. When naloxone (3 mg/kg) was injected 20 min before the morphine in the pimozide-treated rat, plasma prolactin concentration was not affected by morphine indicating that the stimulatory effect of this opioid on prolactin release in the pimozide-pretreated rat was mediated by mu-receptors. We can conclude that morphine can stimulate prolactin release through a mechanism apparently independent of dopaminergic receptors, one possible route being through a putative PRF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907416     DOI: 10.1139/y88-226

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  6 in total

1.  Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.

Authors:  Yu-Jun Wang; Khampaseuth Rasakham; Peng Huang; Darina Chudnovskaya; Alan Cowan; Lee-Yuan Liu-Chen
Journal:  J Pharmacol Exp Ther       Date:  2011-08-12       Impact factor: 4.030

2.  Variation in tolerance to the antinociceptive, hormonal and thermal effects of morphine after a 5-day pre-treatment of male rats with increasing doses of morphine.

Authors:  P T Männistö; S A Borisenko; P Rauhala; P Tuomainen; R K Tuominen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

3.  Effects of nalbuphine on anterior pituitary and adrenal hormones and subjective responses in male cocaine abusers.

Authors:  Nathalie V Goletiani; Jack H Mendelson; Michelle B Sholar; Arthur J Siegel; Alicja Skupny; Nancy K Mello
Journal:  Pharmacol Biochem Behav       Date:  2007-02-20       Impact factor: 3.533

4.  Mu and kappa opioid receptor expression in the mediobasal hypothalamus and effectiveness of selective antagonists on prolactin release during lactation.

Authors:  M Tavakoli-Nezhad; L A Arbogast
Journal:  Neuroscience       Date:  2010-01-04       Impact factor: 3.590

5.  Is opium addiction a risk factor for bone loss?

Authors:  M H Gozashti; A Shahesmaeili; N Amini Zadeh
Journal:  Iran Red Crescent Med J       Date:  2011-07-01       Impact factor: 0.611

6.  Pharmacological causes of hyperprolactinemia.

Authors:  Daria La Torre; Alberto Falorni
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.